Correlation Between Chunghwa Telecom and CRISPR Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chunghwa Telecom and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chunghwa Telecom and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chunghwa Telecom Co, and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Chunghwa Telecom and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chunghwa Telecom with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chunghwa Telecom and CRISPR Therapeutics.

Diversification Opportunities for Chunghwa Telecom and CRISPR Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Chunghwa and CRISPR is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Chunghwa Telecom Co, and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Chunghwa Telecom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chunghwa Telecom Co, are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Chunghwa Telecom i.e., Chunghwa Telecom and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between Chunghwa Telecom and CRISPR Therapeutics

Assuming the 90 days trading horizon Chunghwa Telecom Co, is expected to generate 0.07 times more return on investment than CRISPR Therapeutics. However, Chunghwa Telecom Co, is 14.42 times less risky than CRISPR Therapeutics. It trades about 0.06 of its potential returns per unit of risk. CRISPR Therapeutics AG is currently generating about -0.02 per unit of risk. If you would invest  4,161  in Chunghwa Telecom Co, on November 4, 2024 and sell it today you would earn a total of  155.00  from holding Chunghwa Telecom Co, or generate 3.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

Chunghwa Telecom Co,  vs.  CRISPR Therapeutics AG

 Performance 
       Timeline  
Chunghwa Telecom Co, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chunghwa Telecom Co, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical indicators, Chunghwa Telecom is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
CRISPR Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Chunghwa Telecom and CRISPR Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chunghwa Telecom and CRISPR Therapeutics

The main advantage of trading using opposite Chunghwa Telecom and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chunghwa Telecom position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.
The idea behind Chunghwa Telecom Co, and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamental Analysis
View fundamental data based on most recent published financial statements